Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Biotech stocks to watch ahead of liver disease conference
CNBC
Fri, 11/7/14 - 03:54 pm
Tags:
liver disease, Gilead Sciences, Intercept Pharma, Genfit, Merck, Achillion, AbbVie, NASH, hepatitis B, hepatitis C
Gilead Sciences: Another Big Jump in Hep-C Prescriptions
Barron's
Fri, 11/7/14 - 10:30 am
Tags:
Gilead Sciences, hepatitis C, Sovaldi, Harvoni
Why AbbVie Inc.'s Game-Changing New Drug Could Be a Serious Threat to Gilead Sciences Inc.
Motley Fool
Fri, 11/7/14 - 10:11 am
Tags:
AbbVie, Gilead Sciences, Enanta, Harvoni, hepatitis C
Sovaldi's not the only superhero launch: Meet the rest of the pharma Avengers
Fierce Pharma Marketing
Thu, 11/6/14 - 09:03 am
Tags:
Sovaldi, Gilead Sciences, Eyelea, Tecfidera, Zytiga, Kalydeco, Vertex Pharmaceuticals, Victoza, Novo Nordisk, Gilenya, Yervoy, Xtandi, Stribild, Stelara
J&J Wins U.S. Approval for Hepatitis C Combo With Gilead
Bloomberg
Wed, 11/5/14 - 07:38 pm
Tags:
JNJ, FDA, Gilead Sciences, hepatitis C, Olysio
Why Did Gilead Drop Friday? Is It Justified Or Just An Overreaction?
Seeking Alpha
Mon, 11/3/14 - 09:24 am
Tags:
Gilead Sciences, Harvoni
Fundamentals, Technicals Still Intact At Gilead Sciences
Investor's.com
Sat, 11/1/14 - 12:45 pm
Tags:
Gilead Sciences
Gilead Sciences: Harvoni Still Selling Like Hotcakes
Barron's
Fri, 10/31/14 - 02:14 pm
Tags:
Gilead Sciences, hepatitis C, Harvoni
Orphan drug pricing for non-orphan meds? Express Scripts is looking at you, Gilead
Fierce Pharma Marketing
Tue, 10/28/14 - 06:59 pm
Tags:
drug pricing, Express Scripts, Gilead Sciences, Harvoni, Sovaldi
Gilead third-quarter Sovaldi sales dip, but net profit triples
Yahoo/Reuters
Tue, 10/28/14 - 06:49 pm
Tags:
Gilead Sciences, earnings
Locking up Savings? Sovaldi Could be Cost Effective for Prisons: Study
WSJ Pharmalot
Tue, 10/28/14 - 10:32 am
Tags:
Gilead Sciences, hepatitis C, Sovaldi, prisons
Gilead Rises Ahead Of Q3 Earnings As Rivals Wobble
Investors.com
Mon, 10/27/14 - 05:24 pm
Tags:
Gilead Sciences, earnings
If It’s Bad For Merck, It’s Good For Gilead
Barron's
Mon, 10/27/14 - 03:25 pm
Tags:
Merck, Gilead Sciences, hepatitis C, Sovaldi, JNJ, Olysio
3 Biotech Stocks Growing Faster Than Gilead Sciences Inc.
Motley Fool
Mon, 10/27/14 - 08:10 am
Tags:
biotech, Gilead Sciences, Medivation, Astellas, Celgene, Biogen Idec
Biogen Leads 5 Top Biotech Stocks As Earnings Loom
Investors.com
Tue, 10/21/14 - 09:55 pm
Tags:
Biogen Idec, earnings, Celgene, Alexion, Regeneron, Gilead Sciences
What Johnson & Johnson Can Tell Us about Gilead Sciences, inc. Stock
Motley Fool
Mon, 10/20/14 - 08:30 am
Tags:
JNJ, Gilead Sciences, Olysio, hepatitis C, Sovaldi
Gilead's Harvoni Receives Notice of Compliance from Canada
Yahoo/Zacks.com
Fri, 10/17/14 - 07:08 pm
Tags:
Gilead Sciences, Harvoni, hepatitis C, Canada
Should Gilead Sciences, inc. Fear Incoming Competition?
Motley Fool
Wed, 10/15/14 - 02:51 pm
Tags:
Gilead Sciences, hepatitis C, AbbVie, Bristol-Myers Squibb
Gilead Sciences Falls Amid Worries Over Hep-C Drug Price
TheStreet.com
Tue, 10/14/14 - 11:22 am
Tags:
Gilead Sciences, hepatitis C, drug pricing, Harvoni
If AbbVie Discounts its Hep C Drug, Would Pricing Reach a Tipping Point?
WSJ Pharmalot
Tue, 10/14/14 - 09:51 am
Tags:
AbbVie, drug pricing, hepatitis C, Gilead Sciences

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.